Study Comparing Two Anesthetics for Arthroscopic Rotator Cuff Repair
NCT ID: NCT07093905
Last Updated: 2026-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
34 participants
INTERVENTIONAL
2026-01-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rotator Cuff Repair Under Isolated Loco-regional Anesthesia
NCT05848375
Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques for Arthroscopic Shoulder Surgery
NCT01355757
Effect of Perioperative Intravenous Lidocaine Infusion on Postoperative Recovery in Patients Undergoing Arthroscopic Rotator Cuff Repair Under General Anesthesia
NCT04061057
French Cohort of Patients With Rotator Cuff Lesions
NCT06371872
Rotator Cuff Pathway
NCT03717753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study population is composed of adult patients with complete or partial rotator cuff tears requiring reconstructive surgery under anesthesia at Hôpital Privé Clairval or Clinique Monticelli-Vélodrome.
Patients will be seen three times: at inclusion (during the preoperative consultation with the anesthetist), on the day of surgery (hospitalization), and at the follow-up visit (during the postoperative consultation with the surgeon). They will also be contacted by telephone on D1, D3 and D15 to optimize their follow-up. The duration of each patient's participation is approximately one month.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Locoregional anesthesia
patients will benefit from locoregional anesthesia alone by means of an interscalene block of the brachial plexus.
arthroscopy of the shoulder rotator cuff
minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint
Locoregional anesthesia + general anesthesia
patients will benefit from general anesthesia as well as locoregional anesthesia via an interscalene block of the brachial plexus.
arthroscopy of the shoulder rotator cuff
minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
arthroscopy of the shoulder rotator cuff
minimally invasive surgical procedure in which a camera (arthroscope) is inserted into the shoulder joint
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with surgically repairable complete or partial rotator cuff tears;
* American Society of Anesthesiologists Class I to III;
* Patient able to understand study information;
* Patient willing to accept study evaluations and follow-up visits;
* Affiliation with a social insurance plan;
* Patient having been informed and having agreed to participate in the study by signing an informed consent form.
Exclusion Criteria
* Chronic opioid use;
* Patient unable to understand study information (linguistic, psychological, cognitive, etc.);
* Patient unable to answer a self-questionnaire;
* Patient participating in or being excluded from another interventional research study;
* Pregnant or breast-feeding women;
* Protected patient (under legal protection, guardianship or deprived of liberty by judicial or administrative decision).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Euraxi Pharma
INDUSTRY
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Privé Clairval
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00971-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.